Detailed price information for Acadia Pharmaceutica (ACAD-Q) from The Globe and Mail including charting and trades.
Detailed price information for Nuvation Bio Inc (NUVB-N) from The Globe and Mail including charting and trades.
Quant Mutual Fund launches its second Specialized Investment Fund, QSIF Hybrid Long-Short Fund, offering a balanced interval ...
The Company has submitted a supplemental New Drug Application (sNDA) seeking the approval of revumenib for the treatment of R/R mNPM1 AML. The sNDA has been granted Priority Review by the FDA and ...
Phase 2/3 Wave II Clinical Study to Begin in 2026 Completion of Financing to Support Registration Program MONTREAL, Sept. 17, 2025 /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage ...
There is a higher prevalence of heart rate corrected QT (QTc) prolongation in patients with diabetes and metabolic syndrome. QT interval genome-wide association studies have identified candidate genes ...
The U.S. FDA granted accelerated approval to Modeyso for patients with diffuse midline glioma with an H3 K27M mutation with progressive disease. The U.S. Food and Drug Administration (FDA) has granted ...
This cohort study assessed ECG parameters in transgender men and women before and after use of gender-affirming hormone therapies. Testosterone use in transgender men was associated with shorter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback